-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

Benzinga·08/24/2026 14:17:28
Listen to the news
Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and raises the price target from $9 to $11.